TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Teva Pharmaceutical Industries Ltd quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2010 to Q3 2024.
  • Teva Pharmaceutical Industries Ltd Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 1.13B shares, a 1.07% increase year-over-year.
  • Teva Pharmaceutical Industries Ltd annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.12B shares, a 0.81% increase from 2022.
  • Teva Pharmaceutical Industries Ltd annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.11B shares, a 0.73% increase from 2021.
  • Teva Pharmaceutical Industries Ltd annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.1B shares, a 0.64% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.13B +12M +1.07% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 1.13B +13M +1.16% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 1.12B +8M +0.72% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 1.12B +9M +0.81% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-12
Q3 2023 1.12B +10M +0.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 1.12B +10M +0.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 1.12B +8M +0.72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 1.11B +8M +0.73% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-12
Q3 2022 1.11B +8M +0.73% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1.11B +7M +0.64% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 1.11B +8M +0.73% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 1.1B +7M +0.64% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-12
Q3 2021 1.1B +7M +0.64% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 1.1B +7M +0.64% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 1.1B +6M +0.55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 1.1B +4M +0.37% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-10
Q3 2020 1.1B +4M +0.37% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 1.1B +4M +0.37% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 1.09B +3M +0.28% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 1.09B +70M +6.86% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 1.09B +74M +7.27% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 1.09B +74M +7.27% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 1.09B +73M +7.18% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 1.02B +5M +0.49% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-10
Q3 2018 1.02B +1M +0.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 1.02B +1M +0.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 1.02B +1M +0.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 1.02B +61M +6.39% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 1.02B +38M +3.88% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 1.02B +103M +11.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 1.02B +103M +11.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 955M +100M +11.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-12
Q3 2016 979M +128M +15% Jul 1, 2016 Sep 30, 2016 6-K 2017-11-02
Q2 2016 914M +65M +7.66% Apr 1, 2016 Jun 30, 2016 6-K 2017-08-03
Q1 2016 913M +62M +7.29% Jan 1, 2016 Mar 31, 2016 6-K 2017-05-11
Q4 2015 855M +2M +0.23% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-12
Q3 2015 851M -4M -0.47% Jul 1, 2015 Sep 30, 2015 6-K 2016-11-15
Q2 2015 849M -3M -0.35% Apr 1, 2015 Jun 30, 2015 6-K 2016-08-04
Q1 2015 851M +1M +0.12% Jan 1, 2015 Mar 31, 2015 6-K 2016-05-09
Q4 2014 853M +4M +0.47% Oct 1, 2014 Dec 31, 2014 20-F 2017-02-15
Q3 2014 855M +10M +1.18% Jul 1, 2014 Sep 30, 2014 6-K 2015-10-29
Q2 2014 852M +3M +0.35% Apr 1, 2014 Jun 30, 2014 6-K 2015-07-30
Q1 2014 850M -5M -0.59% Jan 1, 2014 Mar 31, 2014 6-K 2015-04-30
Q4 2013 849M -23M -2.64% Oct 1, 2013 Dec 31, 2013 20-F 2016-02-11
Q3 2013 845M -24M -2.76% Jul 1, 2013 Sep 30, 2013 6-K 2014-10-30
Q2 2013 849M -22M -2.53% Apr 1, 2013 Jun 30, 2013 6-K 2014-07-31
Q1 2013 855M -25M -2.84% Jan 1, 2013 Mar 31, 2013 6-K 2014-05-02
Q4 2012 872M -18M -2.02% Oct 1, 2012 Dec 31, 2012 20-F 2015-02-09
Q3 2012 869M -19M -2.14% Jul 1, 2012 Sep 30, 2012 6-K 2013-10-31
Q2 2012 871M -21M -2.35% Apr 1, 2012 Jun 30, 2012 6-K 2013-08-01
Q1 2012 880M -17M -1.9% Jan 1, 2012 Mar 31, 2012 6-K 2013-05-02
Q4 2011 890M -6M -0.67% Oct 1, 2011 Dec 31, 2011 20-F 2014-02-10
Q3 2011 888M -11M -1.22% Jul 1, 2011 Sep 30, 2011 6-K 2012-11-01
Q2 2011 892M -3M -0.34% Apr 1, 2011 Jun 30, 2011 6-K 2012-08-02
Q1 2011 897M +5M +0.56% Jan 1, 2011 Mar 31, 2011 6-K 2012-05-09
Q4 2010 896M Oct 1, 2010 Dec 31, 2010 20-F 2013-02-12
Q3 2010 899M Jul 1, 2010 Sep 30, 2010 6-K 2011-11-02
Q2 2010 895M Apr 1, 2010 Jun 30, 2010 6-K 2011-07-28
Q1 2010 892M Jan 1, 2010 Mar 31, 2010 6-K 2011-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.